Fund Holdings — Propel Bio Management, LLC

Total Portfolio Value:
$191.09M
Total Bought:
$49.51M
Total Sold:
$42.35M
Net Transaction:
+$7.16M
Notable People:
Leen Kawas, James Francis Harding
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Plains GP Holdings, L.P.COMM(PAGP)1,272,3601,272,3600$30.18M$30.88M16.16%+$699.8K
Achieve Life Sciences IncCOMM3,786,4254,034,018+247,593$11.37M$26.34M13.79%+$14.97M
Corcept Therapeutics IncorporatedCOMM(CORT)147,828136,499-11,329$6.02M$11.87M6.21%+$5.85M
Phathom Pharmaceuticals, Inc.COMM(PHAT)841,2721,050,358+209,086$9.35M$11.40M5.96%+$2.04M
Delcath Systems, Inc.COMM(DCTH)979,698871,460-108,238$9.16M$10.97M5.74%+$1.81M
Milestone Pharmaceuticals Inc.COMM(MIST)4,118,3217,429,590+3,311,269$5.08M$9.96M5.21%+$4.87M
COMPASS Pathways plcADRS(CMPS)742,049573,086-168,963$4.12M$8.11M4.24%+$3.99M
Kyverna Therapeutics, Inc.COMM(KYTX)644,421883,198+238,777$5.59M$7.87M4.12%+$2.28M
Artiva Biotherapeutics, Inc.COMM(ARTV)146,369696,436+550,067$949.8K$6.76M3.54%+$5.81M
Abeona Therapeutics Inc.COMM(ABEO)1,329,899983,070-346,829$6.01M$6.08M3.18%+$67.4K
Aquestive Therapeutics InCOMM710,9881,442,397+731,409$2.95M$6.00M3.14%+$3.05M
Palisade Bio, Inc.COMM(PALI)1,115,0002,582,388+1,467,388$2.00M$5.40M2.82%+$3.40M
Immunic, Inc.COMM(IMUX)0325,022+325,022$0$5.00M2.61%+$5.00M
Inventiva S.A.COMM(IVA)724,6781,281,212+556,534$3.99M$4.84M2.53%+$848.4K
SAB Biotherapeutics, Inc.COMM(SABS)1,012,7901,076,578+63,788$3.89M$4.20M2.20%+$312.2K
Orchestra BioMed Holdings, Inc.COMM(OBIO)896,701896,7010$3.83M$3.87M2.02%+$38.5K
Celldex Therapeutics, Inc.COMM(CLDX)131,364103,695-27,669$4.14M$3.86M2.02%-$276.6K
Zevra Therapeutics, Inc.COMM(ZVRA)282,418253,544-28,874$2.64M$3.64M1.90%+$995.0K
Ocular Therapeutix, Inc.COMM(OCUL)382,375357,966-24,409$3.23M$3.52M1.84%+$289.1K
4d Molecular Therapeutics InCOMM380,420252,654-127,766$3.58M$3.36M1.76%-$220.9K
Ovid Therapeutics Inc.COMM(OVID)921,4571,115,538+194,081$2.04M$3.00M1.57%+$963.0K
EyePoint, Inc.COMM(EYPT)215,825191,745-24,080$2.79M$2.74M1.43%-$47.0K
Upstream Bio, Inc.COMM(UPB)341,779350,389+8,610$3.10M$2.42M1.27%-$675.4K
Scynexis IncCOMM0543,478+543,478$0$2.21M1.16%+$2.21M
Silence Therapeutics plcADRS(SLN)0191,733+191,733$0$2.11M1.10%+$2.11M
LeonaBio, Inc.COMM(LONA)149,279149,2790$1.50M$1.37M0.72%-$123.9K
Maze Therapeutics, Inc.COMM(MAZE)43,79843,7980$1.31M$1.31M0.68%-$438
Corvus Pharmaceuticals, Inc.COMM(CRVS)85,79170,380-15,411$1.25M$1.05M0.55%-$199.6K
Sagimet Biosciences Inc.COMM(SGMT)0125,878+125,878$0$973.0K0.51%+$973.0K
Aldeyra Therapeutics, Inc.(ALDX)730,6060-730,606$1.23M$0—-$1.23M
Coherus Oncology, Inc.(CHRS)1,420,5500-1,420,550$2.41M$0—-$2.41M
Connect Biopharma Holdings LimitedSHS(CNTB)209,4930-209,493$553.9K$0—-$553.9K
Evommune, Inc.(EVMN)55,6640-55,664$1.28M$0—-$1.28M
Immunic, Inc.(IMUX)2,344,7790-2,344,779$2.62M$0—-$2.62M
Kalaris Therapeutics, Inc.(KLRS)295,7710-295,771$1.72M$0—-$1.72M
Nuvation Bio Inc.CL A(NUVB)329,2960-329,296$1.41M$0—-$1.41M
Oculis Holding AG(OCS)122,2230-122,223$3.28M$0—-$3.28M
Satellos Bioscience Inc.(MSLE)10,1450-10,145$57.1K$0—-$57.1K
Trevi Therapeutics, Inc.(TRVI)223,8020-223,802$2.65M$0—-$2.65M
uniQure N.V.SHS(QURE)104,7720-104,772$1.71M$0—-$1.71M
Viridian Therapeutics, Inc.(VRDN)210,1630-210,163$4.09M$0—-$4.09M
Vor Biopharma Inc.(VOR)314,5430-314,543$5.59M$0—-$5.59M
Page 1 of 1